Aloracetam
Alternative Names: CAS 493Latest Information Update: 26 Oct 1995
At a glance
- Originator Aventis
- Class Anti-ischaemics; Neuroprotectants; Nootropics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 26 Oct 1995 Discontinued-I for Alzheimer's disease in Japan (Unknown route)
- 26 Oct 1995 Discontinued-II for Alzheimer's disease in Germany (Unknown route)
- 13 Dec 1994 No-Development-Reported for Alzheimer's disease in Germany (Unknown route)